ADMA vs AMT · P/E 22, rev $238.9M vs P/E 31, rev $10.64B
ADMA Biologics Inc (ADMA) versus American Tower Corp (AMT) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Not investment advice. Open the ADMA and AMT stock pages for the full models.
Not investment advice.